This list is an analysis based on recent market events. It's not an investment recommendation.
About
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.
The current price of OSTX is $1.36 USD — it has increased by +0% in the past 24 hours. Watch OS Therapies stock price performance more closely on the chart.
What is OS Therapies stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange OS Therapies stocks are traded under the ticker OSTX.
Is OS Therapies stock price growing?▼
OSTX stock has fallen by -3.55% compared to the previous week, the month change is a -9.93% fall, over the last year OS Therapies has showed a -2.86% decrease.
What is OS Therapies market cap?▼
Today OS Therapies has the market capitalization of 47.89M
When is the next OS Therapies earnings date?▼
OS Therapies is going to release the next earnings report on April 06, 2026.
What were OS Therapies earnings last quarter?▼
OSTX earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.12 USD resulting in a -71.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is OS Therapies revenue for the last year?▼
OS Therapies revenue for the last year amounts to 0 USD.
What is OS Therapies net income for the last year?▼
OSTX net income for the last year is -21.77M USD.
How many employees does OS Therapies have?▼
As of April 05, 2026, the company has 4 employees.